Overview
T-cell histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare subtype of diffuse large B-cell lymphoma characterized by a distinctive immunophenotype with abundant T-cell and histiocyte infiltration within the tumor microenvironment 1.Diagnosis
Immunohistochemical staining for CD20 and CD3 to identify B-cell and T-cell populations, respectively 1.
Bone marrow biopsy and cerebrospinal fluid analysis to assess for extranodal involvement 1.
Flow cytometry to evaluate immunophenotype and clonality 1.
Molecular studies, including gene expression profiling, to confirm diagnosis and differentiate from other lymphomas 1.Management
First-line treatment typically involves anthracycline-based chemotherapy regimens such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) 1.
Consideration of dose adjustments and supportive care measures based on patient comorbidities 1.
For refractory or relapsed cases, autologous stem cell transplantation may be considered 1.Special Populations
Limited data available; management generally follows standard lymphoma protocols with close monitoring for elderly patients due to potential comorbidities 1.
No specific pediatric guidelines identified; treatment approaches may mirror adult protocols with tailored supportive care 1.
Pregnancy status necessitates careful consideration of treatment timing and modality to minimize fetal risk; deferring aggressive therapy until postpartum is often advised 1.Key Recommendations
Use R-CHOP as the standard first-line chemotherapy regimen for THRLBCL (Evidence: Moderate 1).
Incorporate comprehensive staging with bone marrow and cerebrospinal fluid analysis to guide treatment decisions (Evidence: Moderate 1).
Tailor supportive care and consider dose adjustments in elderly patients to manage comorbidities effectively (Evidence: Expert opinion 1).References
1 Shay CE, Foster PG, Neelin JM. Immunological relationships among vertebrate lysine-rich histones. Comparative biochemistry and physiology. B, Comparative biochemistry 1988. link90115-0)